Scott Rottinghaus

Company: Alexion Pharmaceuticals
Job title: Vice President & Head of Clinical Development, Hematology & Nephrology
Seminars:
Panel Discussion: Navigating Earlier Endpoint Development to Predict Clinical Outcome in Shorter Clinical Trials 11:30 am
Can we move towards harmonizing global regulatory endpoints? Non-invasive imaging, patient-reported outcomes, albuminuria and UACR: driving progress in elevating alternative outcome measures Can we incorporate patient reported outcomes in symptomatic kidney diseases?Read more
day: Day One